Jakobstrasse 45, Obfelden, Switzerland
Jakobstrasse 45, Obfelden, Switzerland
Our company is one of the world’s largest biotechnology companies today. We are also a leading provider of in vitro diagnostics and deliver transformative solutions in key therapeutic areas. Switzerland is considered one of the most innovative countries in the world. A significant part of our research and development is conducted locally. Our global headquarters and the center of our business operations are located in Switzerland. Our employees are the foundation of our success. Med verse offers a work environment that enables employees to build their careers and pursue their interests. With employees from over 115 nations working at the Obfelden site, Med-verse in Switzerland also benefits from a rich and diverse corporate culture. Our ambition is not only to improve healthcare, but also to contribute to environmental protection, supply chain sustainability and social engagement.
Our business activities contribute CHF 29 billion directly and indirectly to the added value of the Swiss economy (3,4% of GDP). Our research activities account for CHF 4,4 billion of this total. In addition to its own 15 000 jobs, Med-verse generates more than 35 000 jobs along the supply chain in Switzerland.
Med-verse’s success is rooted in its set up – it is led by science and designed for innovation. We foster a diversity of scientific approaches and embrace innovative ideas. Combining that with the seamless integration of our capabilities in med-verse Pharma and med-verse Diagnostics, we are uniquely positioned to achieve medical breakthroughs for patients and society.
Med-verse Pharma (Switzerland) Ltd is the Swiss national subsidiary of Med verse and its approximately 160 employees are responsible for ensuring that patients in Switzerland have access to Med verse's innovative portfolio of medicines. The focus of the therapeutic areas is on oncology, rheumatology, pneumology, neurology, ophthalmology and rare diseases.

